Biofrontera, which sells treatments for skin conditions caused by sun damage, filed on Friday with the SEC to raise up to $22 million in an initial public offering.
The Germany-based company was founded in 1997 and booked $12 million in sales for the 12 months ended June 30, 2017. It plans to list on the Nasdaq under the symbol BFRA. Biofrontera filed confidentially on October 4, 2017. The Benchmark Company is the sole bookrunner on the deal. No pricing terms were disclosed.
